Cellular Therapies

AABB first became involved in issues concerning hematopoietic progenitor cells (HPCs) in 1983 to update blood facilities about the special needs that bone marrow transplant patients have for hematologic support. As the field has evolved to include collection, processing, storage, and distribution of HPCs and other cell therapy products, AABB has expanded services to offer related programs in education, standards, and accreditation, along with numerous resources and reference tools. This section includes information on topics relating to cellular therapy as well as resources for the cellular therapy professional.

Hot Topics

Practice Snapshots
Presentation Before the Advisory Council on Blood and Stem Cell Transplantation on AABB Cord Blood Standards and Accreditation Programs – 4/28/08 (PDF)
Letter to AMA on Cord Blood Banking
FDA Approves Mini-Pool Testing of Certain HCT/Ps for HIV/HCV NAT
Joint Comments on Draft Guidance for Cord Blood Licensure (PDF)
Comments on Draft Guidance for Cord Blood Licensure
Cellular Therapy Coding and Labeling Advisory Group (CTCLAG) Documents and Responses
AABB Urges Recognition of all Cord Blood Accrediting Agencies
ISBT 128 for Cellular Therapy
Analysis of Draft Guidance on Licensing of Cord Blood
Analysis of Guidance on Retesting Previously Screened HCT/Ps

Meeting Summaries

FDA Liaison Meeting 2/5/08
FDA Liaison Meeting 6/7/07
FDA Liaison Meeting 1/4/07
FDA Liaison Meeting 6/16/06
FDA Liaison Meeting 1/27/06
FDA Liaison Meeting 6/24/05

Resources

Billing and Reimbursement for Stem Cell Processing Q & A
Newsletter: Noteworthy Issues
Facts About Cellular Therapies
Cord Blood Donation FAQs
AABB Accredited Cord and HPC Facilities 
Publications: Cell Therapy
AABB Billing Guide
Donor History Questionnaire
Circular of Information
Commendable Practices Library
Production Assistance for Cellular Therapies (PACT)
 

Quick Links:

• Accreditation
• Standard Setting Activities
• Upcoming Events: Cell Therapy
• Regulatory Information
• Contact Cellular Therapy

Top